CLSN logo

Imunon (CLSN) Stock

Profile

Full Name:

Celsion Corporation

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

27 October 1993

Indexes:

Not included

Description:

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and vaccines. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for the treatment of primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product, which is in Phase II clinical trials for the localized treatment of ovarian cancers. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 15, 2021

Recent annual earnings:

Mar 19, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 01, 2022

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with CLSN included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of Imunon?
  • What is the ticker symbol for Imunon?
  • Does Imunon pay dividends?
  • What sector is Imunon in?
  • What industry is Imunon in?
  • What country is Imunon based in?
  • When did Imunon go public?
  • Is Imunon in the S&P 500?
  • Is Imunon in the NASDAQ 100?
  • Is Imunon in the Dow Jones?
  • When was Imunon's last earnings report?
  • When does Imunon report earnings?

What is the primary business of Imunon?

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and vaccines. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for the treatment of primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product, which is in Phase II clinical trials for the localized treatment of ovarian cancers. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

What is the ticker symbol for Imunon?

The ticker symbol for Imunon is NASDAQ:CLSN

Does Imunon pay dividends?

No, Imunon does not pay dividends

What sector is Imunon in?

Imunon is in the Healthcare sector

What industry is Imunon in?

Imunon is in the Biotechnology industry

What country is Imunon based in?

Imunon is headquartered in United States

When did Imunon go public?

Imunon's initial public offering (IPO) was on 27 October 1993

Is Imunon in the S&P 500?

No, Imunon is not included in the S&P 500 index

Is Imunon in the NASDAQ 100?

No, Imunon is not included in the NASDAQ 100 index

Is Imunon in the Dow Jones?

No, Imunon is not included in the Dow Jones index

When was Imunon's last earnings report?

Imunon's most recent earnings report was on 15 November 2021

When does Imunon report earnings?

The date for Imunon's next earnings report has not been announced yet